CMCVentures is a strategic communications firm that supports emerging growth companies in effectively communicating their story to investors.
No link added
Groundbreaking therapies that could change the treatment landscape for PTSD, fibromyalgia, MS & Alzheimer’s
Silo Pharma is betting on a mix of familiar medicines and psychedelic-inspired science to tackle conditions like PTSD, chronic pain, Alzheimer’s, and multiple sclerosis—using novel delivery methods like nasal sprays and tiny implants. The big question is whether its early test results and research partners can translate into human trials before funding needs and regulatory hurdles slow things down.Read more
Scaling up in building materials with smart M&A and growing profitability
Capstone turns a former biotech shell into a roll-up business selling stone veneer and masonry supplies, aiming to stitch together many small regional distributors into a larger, national platform. New in-house product lines, expansion into new regions, and a cleaner cost base could lift profitability—but it depends on pulling off acquisitions without overreaching in a construction market that can cool quickly.Read more